These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8248098)

  • 21. Sequential 1H NMR assignments of kistrin, a potent platelet aggregation inhibitor and glycoprotein IIb-IIIa antagonist.
    Adler M; Wagner G
    Biochemistry; 1992 Feb; 31(4):1031-9. PubMed ID: 1734953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional analysis and modeling of a conformationally constrained Arg-Gly-Asp sequence inserted into human lysozyme.
    Yamada T; Uyeda A; Kidera A; Kikuchi M
    Biochemistry; 1994 Oct; 33(39):11678-83. PubMed ID: 7522552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Halysin, an antiplatelet Arg-Gly-Asp-containing snake venom peptide, as fibrinogen receptor antagonist.
    Huang TF; Liu CZ; Ouyang CH; Teng CM
    Biochem Pharmacol; 1991 Aug; 42(6):1209-19. PubMed ID: 1888330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteolytic degradation of the RGD-binding and non-RGD-binding conformers of human platelet integrin glycoprotein IIb/IIIa: clues for identification of regions involved in the receptor's activation.
    Calvete JJ; Mann K; Schäfer W; Fernandez-Lafuente R; Guisán JM
    Biochem J; 1994 Feb; 298 ( Pt 1)(Pt 1):1-7. PubMed ID: 8129707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective recognition of cyclic RGD peptides of NMR defined conformation by alpha IIb beta 3, alpha V beta 3, and alpha 5 beta 1 integrins.
    Pfaff M; Tangemann K; Müller B; Gurrath M; Müller G; Kessler H; Timpl R; Engel J
    J Biol Chem; 1994 Aug; 269(32):20233-8. PubMed ID: 8051114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Competition for related but nonidentical binding sites on the glycoprotein IIb-IIIa complex by peptides derived from platelet adhesive proteins.
    Santoro SA; Lawing WJ
    Cell; 1987 Mar; 48(5):867-73. PubMed ID: 3493077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of a gain of function mutation of integrin alpha IIb beta 3 (platelet glycoprotein IIb-IIIa).
    Bajt ML; Loftus JC; Gawaz MP; Ginsberg MH
    J Biol Chem; 1992 Nov; 267(31):22211-6. PubMed ID: 1429573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of integrin-mediated platelet aggregation, fibrinogen-binding, and interactions with extracellular matrix by nonpeptidic mimetics of Arg-Gly-Asp.
    Varon D; Lider O; Dardik R; Shenkman B; Alon R; Hershkoviz R; Kapustina G; Savion N; Martinowitz U; Greenspoon N
    Thromb Haemost; 1993 Dec; 70(6):1030-6. PubMed ID: 8165596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet receptor recognition domains on the alpha chain of human fibrinogen: structure-function analysis.
    Hawiger J; Kloczewiak M; Bednarek MA; Timmons S
    Biochemistry; 1989 Apr; 28(7):2909-14. PubMed ID: 2742818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of fibrinogen alpha and gamma chain sites in platelet aggregation.
    Farrell DH; Thiagarajan P; Chung DW; Davie EW
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10729-32. PubMed ID: 1438269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mambin, a potent glycoprotein IIb-IIIa antagonist and platelet aggregation inhibitor structurally related to the short neurotoxins.
    McDowell RS; Dennis MS; Louie A; Shuster M; Mulkerrin MG; Lazarus RA
    Biochemistry; 1992 May; 31(20):4766-72. PubMed ID: 1591238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The amino acid sequence Gly-Ala-Pro-Leu appears to be a fibrinogen binding site in the platelet integrin, glycoprotein IIb.
    Gartner TK; Taylor DB
    Thromb Res; 1990 Nov; 60(4):291-309. PubMed ID: 1708172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The peptides APLHK, EHIPA and GAPL are hydropathically equivalent peptide mimics of a fibrinogen binding domain of glycoprotein IIb/IIIa.
    Gartner TK; Loudon R; Taylor DB
    Biochem Biophys Res Commun; 1991 Nov; 180(3):1446-52. PubMed ID: 1953789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacophore refinement of gpIIb/IIIa antagonists based on comparative studies of antiadhesive cyclic and acyclic RGD peptides.
    Müller G; Gurrath M; Kessler H
    J Comput Aided Mol Des; 1994 Dec; 8(6):709-30. PubMed ID: 7738606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kistrin, an integrin antagonist, blocks endocytosis of fibrinogen into guinea pig megakaryocyte and platelet alpha-granules.
    Handagama P; Bainton DF; Jacques Y; Conn MT; Lazarus RA; Shuman MA
    J Clin Invest; 1993 Jan; 91(1):193-200. PubMed ID: 8423218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of the principal binding site for RGD-containing ligands in the alpha(V)beta(3) integrin: a photoaffinity cross-linking study.
    Yahalom D; Wittelsberger A; Mierke DF; Rosenblatt M; Alexander JM; Chorev M
    Biochemistry; 2002 Jul; 41(26):8321-31. PubMed ID: 12081480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endogenous platelet fibrinogen surface expression on activated platelets.
    Gralnick HR; Williams S; McKeown L; Connaghan G; Shafer B; Hansmann K; Vail M; Fenton J
    J Lab Clin Med; 1991 Dec; 118(6):604-13. PubMed ID: 1744509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The cystine knot of a squash-type protease inhibitor as a structural scaffold for Escherichia coli cell surface display of conformationally constrained peptides.
    Christmann A; Walter K; Wentzel A; Krätzner R; Kolmar H
    Protein Eng; 1999 Sep; 12(9):797-806. PubMed ID: 10506290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycoprotein IIb peptide 656-667 mimics the fibrinogen gamma chain 402-411 binding site on platelet integrin GPIIb/IIIa.
    Calvete JJ; Rivas G; Schäfer W; McLane MA; Niewiarowski S
    FEBS Lett; 1993 Nov; 335(1):132-5. PubMed ID: 8243658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design of orally active, non-peptide fibrinogen receptor antagonists. An evolutionary process from the RGD sequence to novel anti-platelet aggregation agents.
    Bovy PR; Tjoeng FS; Rico JG; Rogers TE; Lindmark RJ; Zablocki JA; Garland RB; McMackins DE; Dayringer H; Tóth MV
    Bioorg Med Chem; 1994 Sep; 2(9):881-95. PubMed ID: 7712124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.